NCT04851249

Brief Summary

Prospective observational study to evaluate the clinical and radiological predictors for outcome in hallux valgus (HV) corrective surgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
19mo left

Started Jan 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Jan 2022Dec 2027

First Submitted

Initial submission to the registry

April 9, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 20, 2021

Completed
9 months until next milestone

Study Start

First participant enrolled

January 1, 2022

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

July 10, 2024

Status Verified

July 1, 2024

Enrollment Period

4.9 years

First QC Date

April 9, 2021

Last Update Submit

July 9, 2024

Conditions

Keywords

Hallux valgusOutcome predictorsMOXFQ

Outcome Measures

Primary Outcomes (1)

  • Comparing the pre and postoperative Manchester-Oxford Foot Questionnaire (MOXFQ) index score in participants operated for hallux valgus deformity

    The MOXFQ (Dawson et al., 2006) was developed to measure perceived foot-specific functioning and health-related quality of life. The MOXFQ is supported as the current most valid, reliable and responsive foot \& ankle instrument (Jia, Huang\&Gagnier, 2017). It is available in Norwegian, but has not been validated in its translated form. The score compromises a total of 16 items. They are distributed within 3 dimensions; foot pain (5 items), walking/standing (7 items) and social interaction (4 items) where all items are scored on a 5-point Likert scale, score 0 (best) to 4 (worst). The MOXFQ index score (Morely et al., 2013) will be used as the main outcome and we define an increase of at least 15 points as a successful outcome. We plan to run multiple regression analysis with baseline parameters as well as radiological and Patient-reported outcome measures (PROMs) data as predictors. To account for loss to follow-up we will include 250 patients in this study.

    Participant enrollment is expected to be completed within 3-4 years time, they will be evaluated preoperatively, 6 weeks, 12 weeks and 52 weeks postoperatively

Secondary Outcomes (1)

  • Comparing the traditional and newer rotational radiological parameters with PROMs pre and postoperatively

    Participant enrollment is expected to be completed within 3-4 years time, patient follow-up 6, 12 and 52 weeks postoperatively. Goal of inclusion 250 patients.

Study Arms (1)

Adult participants operated for Hallux Valgus deformity

All adult participants accepted for hallux valgus corrective surgery at ostfold hospital trust (ØHT) is asked to participate in the study. The goal is to include 200-250 participants.

Procedure: Hallux Valgus - chevron osteotomy, lapidus procedure

Interventions

The purpose is to compare the preoperative clinical features (previous medical history, age, BMI, occupational status etc), PROMs (Manchester-Oxford Foot and ankle questionnaire, SF-36, VAS activity scale) and radiological parameters (both two and three dimensional) with the postoperative PROMs (+ likert scale) and the postoperative radiological parameters.

Adult participants operated for Hallux Valgus deformity

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All adult patients accepted for hallux valgus surgery at the ØHT

You may qualify if:

  • All adult patients accepted for hallux valgus surgery (mild, moderate, severe) at the ØHT will be asked to participate in the study

You may not qualify if:

  • Previous hallux valgus surgery in the same foot
  • Lack of compliance
  • Not available for follow-up
  • Language difficulties (not able to communicate in English or Norwegian)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Østfold Hospital Trust

Sarpsborg, Østfold fylke, 1714, Norway

RECRUITING

MeSH Terms

Conditions

Hallux Valgus

Condition Hierarchy (Ancestors)

Foot DeformitiesMusculoskeletal Diseases

Study Officials

  • Marius Molund, MD, PhD

    Head of foot and ankle department at ØHT

    STUDY DIRECTOR

Central Study Contacts

Marius Molund, MD, PhD

CONTACT

Mikaela Engarås Hamre, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 9, 2021

First Posted

April 20, 2021

Study Start

January 1, 2022

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

July 10, 2024

Record last verified: 2024-07

Locations